Medical Review Board Meeting, Public Listening Session, 11423-11424 [E7-4468]

Download as PDF Federal Register / Vol. 72, No. 48 / Tuesday, March 13, 2007 / Notices Daytona Beach, Florida, United States of America. FOR FURTHER INFORMATION CONTACT: (1) RTCA Secretariat, 1828 L Street, NW., Suite 805, Washington, DC 20036; telephone (202) 833–9339; fax (202) 833–9434; Web site https://www.rtca.org; (2) Joint Secretaries, Europe: Mr. Ross Hannon, telephone +44 78807–46650, email: ross_hannon@binternet.com; US: Mr. Michael DeWalt, telephone (206) 972–0170, e-mail: mike.dewalt@certification.com. Pursuant to Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92– 463, 5 U.S.C., Appendix 2), notice is hereby given for a Special Committee 205/EUROCAE Working Group 71 meeting: SUPPLEMENTARY INFORMATION: Note: On arrival at ERAU please have photo identification available (either a passport, a drivers license bearing a photograph or an identity card) to assist in your badge being issued. • • • • cprice-sewell on PROD1PC66 with NOTICES • 14:58 Mar 12, 2007 Jkt 211001 Issued in Washington, DC, on March 7, 2007. Francisco Estrada C., RTCA Advisory Committee. [FR Doc. 07–1160 Filed 3–12–07; 8:45 am] BILLING CODE 4910–13–M DEPARTMENT OF TRANSPORTATION The agenda will include: March 19: • Registration. • New Attendees Introductory Session. • Sub-Group Meetings. • Sub-Group Meeting Continue. • Executive Committee/SG Chairs/ Secretaries Meeting. March 20: • Plenary: Chairmen’s Remarks and Introductions, Review/Approve Agenda and 4th Joint Plenary Minutes. • Issue List Status Report, Internet and Serve Access Presentation. • Sub-Group Report Ins and Q & A, Other Reports, and Other Documents. • Sub-Group Meetings. • Executive Committee/SG Chairs/ Secretaries Meeting. March 21: • Sub-Group Meetings. • Plenary Session. March 22: • Sub-Group Meetings. • Plenary Session. • Executive Committee/SG Chairs/ Secretaries Meeting. March 23: • Plenary Session: Report Outs, Evaluation of Papers. • Sub-Group 3: Tool Qualification. • Sub-Group 4: Model Based Design & Verification. • Sub-Group 5: Object Oriented Technology. • Sub-Group 6: Formal Methods. • Sub-Group 7: Special Considerations. • Sub-Group 1: SCWG Document Integration. VerDate Aug<31>2005 • Closing Plenary Session (Other Business, Date and Place of Next Meeting, Meeting Evaluation, Adjourn). Attendance is open to the interested public but limited to space availability. With the approval of the chairmen, members of the public may present oral statements at the meeting. Persons wishing to present statements or obtain information should contact the person listed in the FOR FURTHER INFORMATION CONTACT section. Members of the public may present a written statement to the committee at any time. Federal Motor Carrier Safety Administration [Docket No. FMCSA–2007–27186] Medical Review Board Meeting, Public Listening Session Federal Motor Carrier Safety Administration (FMCSA), United States Department of Transportation (DOT). ACTION: Notice of Medical Review Board (MRB) Meeting and Public Listening Session. AGENCY: SUMMARY: FMCSA announces a meeting and public listening session of the Agency’s MRB. The MRB members will continue deliberations about current FMCSA medical standards, as well as consider recommendations for new science-based standards and guidelines to ensure that the physical condition of drivers is adequate to enable them to safely operate commercial motor vehicles (CMVs) in interstate commerce. In accordance with the Federal Advisory Committee Act (FACA), the MRB meeting is open to the public. DATES: The MRB meeting will be held from 9 a.m. to 3:30 p.m. on April 25, 2007. The public may offer oral comments and ask questions of the MRB members relative to the medical and scientific issues discussed from 1:30 p.m. to 3:30 p.m. ADDRESSES: The MRB meeting will take place at the Crown Plaza Hotel, 1375 South Broadway, Lexington, KY 40504– 2703. You may submit comments identified by DOT Docket Management System (DMS) Docket Number FMCSA– 2007–27186 using any of the following methods: PO 00000 Frm 00104 Fmt 4703 Sfmt 4703 11423 • Web Site: https://dmses.dot.gov/ submit. Follow the instructions for submitting comments on the DOT electronic docket site. • Fax: 1–202–493–2251. • Mail: Docket Management Facility; U.S. Department of Transportation, 400 Seventh Street, SW., Nassif Building, Room PL–401, Washington, DC 20590– 0001. • Hand Delivery: Room PL–401 on the plaza level of the Nassif Building, 400 Seventh Street, SW., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. • Federal eRulemaking Portal: Go to https://www.regulations.gov. Follow the online instructions for submitting comments. Instructions: All submissions must include the Agency name and docket number for this notice. Note that all comments received will be posted without change to https://dms.dot.gov including any personal information provided. Please see the Privacy Act heading for further information. Docket: For access to the docket to read background documents or comments received, go to https:// dms.dot.gov at any time or Room PL– 401 on the plaza level of the Nassif Building, 400 Seventh Street, SW., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. The DMS is available 24 hours each day, 365 days each year. If you want acknowledgment that we received your comments, please include a self-addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments on-line. Privacy Act: Anyone may search the electronic form of all comments received into any of our dockets by the name of the individual submitting the comment (or of the person signing the comment, if submitted on behalf of an association, business, labor union, etc.). You may review the U.S. Department of Transportation’s complete Privacy Act Statement in the Federal Register published on April 11, 2000 (65 FR 19477; Apr. 11, 2000). This information is also available at https://dms.dot.gov. FOR FURTHER INFORMATION CONTACT: Dr. Mary D. Gunnels, Chief, Physical Qualifications Division, 202–366–4001, FMCSA, Department of Transportation, 400 Seventh Street, SW., Washington, DC 20590–0001. Office hours are from 8:30 a.m. to 5 p.m. Monday through Friday, except Federal holidays. Information on Services for Individuals With Disabilities For information on facilities or services for individuals with disabilities E:\FR\FM\13MRN1.SGM 13MRN1 11424 Federal Register / Vol. 72, No. 48 / Tuesday, March 13, 2007 / Notices or to request special assistance at the meeting, contact Kaye Kirby at 202– 366–4001. SUPPLEMENTARY INFORMATION: The preliminary agenda for the MRB meeting: 0800–0900 Registration (Includes Request for Comments). 0900–0905 Call to Order, Agenda Review. 0905–0925 MRB Actions, (Diabetes & Schedule II Medications). 0925–0945 Cardiovascular Disease. 0945–1015 Cardiovascular Disease Expert Panel Recommendations. 1015–1100 MRB questions on Cardiovascular Disease. 1100–1130 Deliberations on Evidence Report & Panel Comments. 1130–1200 MRB Recommendations. 1200–1330 Lunch Break (Attendees are responsible for their lunch). 1330–1530 Public Comment. *Breaks will be announced on meeting day and may be adjusted according to schedule changes, other listening session requirements. Medical Review Board Meeting cprice-sewell on PROD1PC66 with NOTICES The U.S. Secretary of Transportation announced on March 7, 2006, the five medical experts who serve on FMCSA’s MRB. Section 4116 of the Safe, Accountable, Flexible, Efficient Transportation Equity Act: A Legacy for Users (SAFETEA–LU, Pub. L. 109–59) requires the Secretary of Transportation with the advice of the MRB to ‘‘establish, review, and revise medical standards for operators of CMVs that will ensure that the physical condition of operators is adequate to enable them to operate the vehicles safely.’’ FMCSA is considering updates to the physical qualification regulations of CMV drivers, and the MRB will provide the necessary science-based guidance to establish realistic and responsible medical standards. The MRB operates in accordance with FACA as announced in the Federal Register (70 FR 57642, October 3, 2005). The MRB is charged initially with the review of all current FMCSA medical standards (49 CFR 391.41), as well as proposing new science-based standards and guidelines to ensure that drivers operating CMVs in interstate commerce, as defined in CFR 390.5, are physically capable of doing so. Meeting Participation Attendance is open to the interested public, including medical examiners, motor carriers, drivers, and representatives of medical and scientific associations. The public can ask relevant questions of the MRB and VerDate Aug<31>2005 14:58 Mar 12, 2007 Jkt 211001 comment about the information presented to the MRB during the listening session of the program, which will be held 1:30 p.m.–3:30 p.m. Written comments for the MRB meeting will also be accepted beginning on March 27, 2007, and continuing until May 17, 2007, and should include the docket number that is listed in the ADDRESSES section. During the MRB meeting, oral comments may be limited depending on how many persons wish to comment; and will be accepted on a first come, first serve basis as requestors register at the meeting. The comments must directly address relevant medical and scientific issues on the MRB meeting agenda. For more information, view the following Web site: https:// www.mrb.fmcsa.dot.gov. Issued on: March 6, 2007. John H. Hill, Administrator. [FR Doc. E7–4468 Filed 3–12–07; 8:45 am] BILLING CODE 4910–EX–P DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket Nos. FMCSA–98–3637, FMCSA–00– 7165, FMCSA–00–7363, FMCSA–00–8203, FMCSA–02–12844, FMCSA–02–12294, FMCSA–04–19477] Qualification of Drivers; Exemption Renewals; Vision Federal Motor Carrier Safety Administration (FMCSA), DOT. ACTION: Notice of final disposition. AGENCY: SUMMARY: FMCSA previously announced its decision to renew the exemptions from the vision requirement in the Federal Motor Carrier Safety Regulations for these 45 individuals. FMCSA has statutory authority to exempt individuals from the vision requirement if the exemptions granted will not compromise safety. The Agency has reviewed the comments submitted in response to the previous announcements and concluded that granting these exemptions will provide a level of safety that will be equivalent to, or greater than, the level of safety maintained without the exemptions for these commercial motor vehicle (CMV) drivers. FOR FURTHER INFORMATION CONTACT: Dr. Mary D. Gunnels, Chief, Physical Qualifications Division, (202) 366–4001, maggi.gunnels@dot.gov, FMCSA, Department of Transportation, 400 Seventh Street, SW., Room 8301, Washington, DC 20590–0001. Office hours are from 8:30 a.m. to 5 p.m., PO 00000 Frm 00105 Fmt 4703 Sfmt 4703 Monday through Friday, except Federal holidays. SUPPLEMENTARY INFORMATION: Electronic Access You may see all the comments online through the Document Management System (DMS) at https://dmses.dot.gov. Background Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption for a 2year period if it finds ‘‘such exemption would likely achieve a level of safety that is equivalent to, or greater than, the level that would be achieved absent such exemption.’’ The statute also allows the Agency to renew exemptions at the end of the 2-year period. The comment period ended on February 8, 2007. Discussion of Comments FMCSA received two comments in these proceedings. The comments were considered and discussed below. Ms. Sachau believes that drivers with impaired vision should not be driving commercially because it makes the roads much more dangerous. A review of each record for safety while driving with the respective vision deficiencies over the past two years indicates each applicant continues to meet the vision exemption standards. To evaluate the effect of these exemptions on safety, FMCSA considered not only the medical reports about the applicants’ vision, but also their driving records and experience with the vision deficiency. To qualify for an exemption from the vision standard, FMCSA requires a person to present verifiable evidence that he or she has driven a commercial vehicle safely with the vision deficiency for 3 years. Recent driving performance is especially important in evaluating future safety, according to several research studies designed to correlate past and future driving performance. Results of these studies support the principle that the best predictor of future performance by a driver is his/her past record of crashes and traffic violations. Copies of the studies may be found at docket number FMCSA–98– 3637. Advocates for Highway and Auto Safety (Advocates) expressed opposition to FMCSA’s policy to grant exemptions from the FMCSR, including the driver qualification standards. Specifically, Advocates: (1) Objects to the manner in which FMCSA presents driver information to the public and makes safety determinations; (2) objects to the Agency’s reliance on conclusions drawn from the vision waiver program; (3) E:\FR\FM\13MRN1.SGM 13MRN1

Agencies

[Federal Register Volume 72, Number 48 (Tuesday, March 13, 2007)]
[Notices]
[Pages 11423-11424]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-4468]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2007-27186]


Medical Review Board Meeting, Public Listening Session

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), United 
States Department of Transportation (DOT).

ACTION: Notice of Medical Review Board (MRB) Meeting and Public 
Listening Session.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces a meeting and public listening session of the 
Agency's MRB. The MRB members will continue deliberations about current 
FMCSA medical standards, as well as consider recommendations for new 
science-based standards and guidelines to ensure that the physical 
condition of drivers is adequate to enable them to safely operate 
commercial motor vehicles (CMVs) in interstate commerce. In accordance 
with the Federal Advisory Committee Act (FACA), the MRB meeting is open 
to the public.

DATES: The MRB meeting will be held from 9 a.m. to 3:30 p.m. on April 
25, 2007. The public may offer oral comments and ask questions of the 
MRB members relative to the medical and scientific issues discussed 
from 1:30 p.m. to 3:30 p.m.

ADDRESSES: The MRB meeting will take place at the Crown Plaza Hotel, 
1375 South Broadway, Lexington, KY 40504-2703. You may submit comments 
identified by DOT Docket Management System (DMS) Docket Number FMCSA-
2007-27186 using any of the following methods:
     Web Site: https://dmses.dot.gov/submit. Follow the 
instructions for submitting comments on the DOT electronic docket site.
     Fax: 1-202-493-2251.
     Mail: Docket Management Facility; U.S. Department of 
Transportation, 400 Seventh Street, SW., Nassif Building, Room PL-401, 
Washington, DC 20590-0001.
     Hand Delivery: Room PL-401 on the plaza level of the 
Nassif Building, 400 Seventh Street, SW., Washington, DC, between 9 
a.m. and 5 p.m., Monday through Friday, except Federal holidays.
     Federal eRulemaking Portal: Go to https://
www.regulations.gov. Follow the online instructions for submitting 
comments.
    Instructions: All submissions must include the Agency name and 
docket number for this notice. Note that all comments received will be 
posted without change to https://dms.dot.gov including any personal 
information provided. Please see the Privacy Act heading for further 
information.
    Docket: For access to the docket to read background documents or 
comments received, go to https://dms.dot.gov at any time or Room PL-401 
on the plaza level of the Nassif Building, 400 Seventh Street, SW., 
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, 
except Federal holidays. The DMS is available 24 hours each day, 365 
days each year. If you want acknowledgment that we received your 
comments, please include a self-addressed, stamped envelope or postcard 
or print the acknowledgement page that appears after submitting 
comments on-line.
    Privacy Act: Anyone may search the electronic form of all comments 
received into any of our dockets by the name of the individual 
submitting the comment (or of the person signing the comment, if 
submitted on behalf of an association, business, labor union, etc.). 
You may review the U.S. Department of Transportation's complete Privacy 
Act Statement in the Federal Register published on April 11, 2000 (65 
FR 19477; Apr. 11, 2000). This information is also available at https://
dms.dot.gov.

FOR FURTHER INFORMATION CONTACT: Dr. Mary D. Gunnels, Chief, Physical 
Qualifications Division, 202-366-4001, FMCSA, Department of 
Transportation, 400 Seventh Street, SW., Washington, DC 20590-0001. 
Office hours are from 8:30 a.m. to 5 p.m. Monday through Friday, except 
Federal holidays.

Information on Services for Individuals With Disabilities

    For information on facilities or services for individuals with 
disabilities

[[Page 11424]]

or to request special assistance at the meeting, contact Kaye Kirby at 
202-366-4001.

SUPPLEMENTARY INFORMATION:
    The preliminary agenda for the MRB meeting:
0800-0900 Registration (Includes Request for Comments).
0900-0905 Call to Order, Agenda Review.
0905-0925 MRB Actions, (Diabetes & Schedule II Medications).
0925-0945 Cardiovascular Disease.
0945-1015 Cardiovascular Disease Expert Panel Recommendations.
1015-1100 MRB questions on Cardiovascular Disease.
1100-1130 Deliberations on Evidence Report & Panel Comments.
1130-1200 MRB Recommendations.
1200-1330 Lunch Break (Attendees are responsible for their lunch).
1330-1530 Public Comment.

    *Breaks will be announced on meeting day and may be adjusted 
according to schedule changes, other listening session requirements.

Medical Review Board Meeting

    The U.S. Secretary of Transportation announced on March 7, 2006, 
the five medical experts who serve on FMCSA's MRB. Section 4116 of the 
Safe, Accountable, Flexible, Efficient Transportation Equity Act: A 
Legacy for Users (SAFETEA-LU, Pub. L. 109-59) requires the Secretary of 
Transportation with the advice of the MRB to ``establish, review, and 
revise medical standards for operators of CMVs that will ensure that 
the physical condition of operators is adequate to enable them to 
operate the vehicles safely.'' FMCSA is considering updates to the 
physical qualification regulations of CMV drivers, and the MRB will 
provide the necessary science-based guidance to establish realistic and 
responsible medical standards.
    The MRB operates in accordance with FACA as announced in the 
Federal Register (70 FR 57642, October 3, 2005). The MRB is charged 
initially with the review of all current FMCSA medical standards (49 
CFR 391.41), as well as proposing new science-based standards and 
guidelines to ensure that drivers operating CMVs in interstate 
commerce, as defined in CFR 390.5, are physically capable of doing so.

Meeting Participation

    Attendance is open to the interested public, including medical 
examiners, motor carriers, drivers, and representatives of medical and 
scientific associations. The public can ask relevant questions of the 
MRB and comment about the information presented to the MRB during the 
listening session of the program, which will be held 1:30 p.m.-3:30 
p.m. Written comments for the MRB meeting will also be accepted 
beginning on March 27, 2007, and continuing until May 17, 2007, and 
should include the docket number that is listed in the ADDRESSES 
section. During the MRB meeting, oral comments may be limited depending 
on how many persons wish to comment; and will be accepted on a first 
come, first serve basis as requestors register at the meeting. The 
comments must directly address relevant medical and scientific issues 
on the MRB meeting agenda. For more information, view the following Web 
site: https://www.mrb.fmcsa.dot.gov.

    Issued on: March 6, 2007.
John H. Hill,
Administrator.
[FR Doc. E7-4468 Filed 3-12-07; 8:45 am]
BILLING CODE 4910-EX-P